Paidion Research, a new CRO focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care), recently opened for business. Headquartered in Durham, N.C., Paidion combines pediatric clinical pharmacology experience with innovative pediatric regulatory strategies and trial methodologies to provide best-in-class service to drug and device development partners in industry, government, academia and nonprofits.